Emerald Health Therapeutics, Inc. has appointed Riaz Bandali as Chief Executive Officer. Mr. Bandali has over 25 years of experience in life sciences, with expertise in global operations, strategy development, innovation cultivation, M&A, and investment management spanning contract clinical and research services, analytical instrumentation, lab services and venture capital. Mr. Bandali most recently served as President, Early Phase Clinical Services, for Syneos Health, an international clinical research organization. Mr. Bandali previously served as President, Early Stage Development, inVentiv Health Clinical; SVP, Strategy and Business Development, AB Sciex and Molecular Devices; Vice President and General Manager, Global Early Stage Development at MDS Pharma Services; and Venture Partner and Vice President, MDS Capital.